In surgery, the practitioner is only aware of a tumor residue, often only posteriorly when symptoms or signs of recurrence appear.Surgisafe responds to this increased patient risk: the surgeon performs a real-time diagnosis thanks to Tamanoir and immediately take the appropriate decisions. Its low cost makes it affordable to all surgical centers. For single use, Tamanoir has its place among the surgical instruments common to all procedures.
The company Surgisafe is developing Tamanoir, an intelligent surgical sensor allowing the detection at low cost, in real time and without learning, the in vivo presence of tumor tissues. The decision for the surgeon allows him to optimize the operating results (limitation of recurrence and re-excision rates, improvement of aesthetic results), Improve the quality of life of the patient and reduce the costs of health care (per and postoperative).
Learn More